Mobia Medical’s Breakthrough Stroke Therapy | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded19 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20058855

Show notes

Mobia Medical’s Q2 2026 results show explosive growth—102% revenue surge to $13.5M—with their groundbreaking Vivistim VNS therapy helping stroke survivors regain upper limb function. The FDA-approved solution, the first of its kind, taps into neuroplasticity to rewire the brain, restoring independence for patients like Tess, who held her child for the first time ten years after her stroke. Backed by a $134M IPO, the company is accelerating commercialization, expanding into 92% more territories, and securing Medicare reimbursement at $45K per patient. With full-year 2026 revenue projected between $54M–$56M (a 69–75% YoY jump), Mobia is poised to redefine stroke recovery by reaching millions with lasting motor impairments. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cbe9abd198be56ea

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.